Liver cancer, one of the leading causes of cancer-related deaths globally, has become a major concern in healthcare. The liver cancer therapeutics market has witnessed rapid growth, driven by the increasing prevalence of liver cancer, advancements in treatment modalities, and the rising demand for innovative therapies. In 2024, the market was valued at USD 2.50 billion and is expected to grow...